CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GEN - Genetic Engineering & Biotech News
Original article

Gene Therapy Extends Lifespan and Reduces Symptoms in Sandhoff Disease Cat Model

Data ReadoutpositiveIntravenous AAV gene therapyPositive
AI Analysis

Summary

Intravenous AAV gene therapy demonstrated positive results in a Sandhoff disease cat model, extending lifespan and reducing neurological symptoms. The findings support further investigation of systemic AAV gene therapy for this rare genetic disorder.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Extended lifespan, reduced neurological symptoms, and improved disease markers in Sandhoff disease cat model

Importance:4/10
Sentiment:
0.70
gene therapySandhoff diseaseAAVpreclinicalcat modelneurological disease
Related Companies

Read the original article

Published by GEN - Genetic Engineering & Biotech News on September 9, 2026 6:00 PM

Read Original